Happy New Year from your friends at Norlase.
If 2020 was a year of transformation, then 2021 was a year of achievement. We ended our first week of the year with CE Mark approval for the LION green laser system, and our last week of the year clocking a 500% year-over-year growth in sales. Our customers now include most of the top-ranked ophthalmic hospitals in the United States. While the ongoing global pandemic created new logistical and personal challenges to overcome, these achievements bookended a year of incredible momentum in several key areas, including product innovation, organizational growth, and brand power.
Here are just a few of the highlights you may have seen in the news:
-
Shortly after its CE Mark approval, LION won the 2021 PRISM Award for photonics innovation in the Medical Device category
-
We announced new global distributor partnerships, expanding our product reach to Croatia, Serbia, Slovenia, Poland, Ukraine, Russia, Japan, and Algeria
-
We were granted a patent by the USPTO for a novel Voice Control System for Ophthalmic Lasers
-
We closed $10.6 million in Series B funding through London-based venture capital firm West Hill Capital.
We were also thrilled to garner increased attention and coverage from key media players in the eye care industry, including Retina Today, Ocular Surgery News, Retinal Physician, and Ophthalmology Management. Several feature articles, highlighting our differentiated technology and approach, reached tens of thousands of eye care professionals in North America and beyond. Behind the scenes, we continued to gain significant traction with clinical thought leaders, leading care institutions, and industry strategic partners.
When live meetings made a long-awaited return in the fourth quarter of last year, it was deeply rewarding that our reputation preceded our arrival, a testament to our team’s immense dedication, professionalism, and capability. We were thankful for the opportunity to engage the eye care community firsthand and showcase our commitment to advancing the standard of care for ophthalmic laser treatment. With global representation (including our team and distributors) and a badass booth, to boot, we like to think it was a live debut for the books.
While the return to live meetings was certainly refreshing, it’s worth mentioning that 2021 was the year that we perfected remote demonstrations and training. Much of this was due to LEAF and LION’s ease of use, intuitive design and user-friendly interface. Our reps and global partners are some of the best in the industry too – so we must also give them credit. We love getting into practices and in front of our customers, and hope we’re able to see more of them this year. When meeting virtually is the only option, we’ll make it as seamless and enjoyable as possible.
The most rewarding aspect of 2021, however, was to see our products help doctors deliver vision-critical treatments around the world. Hearing stories of how LEAF and LION has helped expand the access to eye-care, makes it all worth it for us. Stories such as how Dr. Maria Berrocal carried out a treatment in Puerto Rico during a complete power outage, thanks to the battery-driven LION laser. Or how Retina Global, who we were proud to support throughout the year, were able to bring laser treatments to underserved communities with LION.
Although it’s fun to revel, our success depends on maintaining an eye on the future. In 2022, we will continue to create, develop, and commercialize world-class products that change perceptions, inspire action, and benefit millions of patients around the world. We are eternally grateful for both the success we’ve experienced, the people who made that success possible, and the opportunity to engage and serve our customers, both today, tomorrow, and well into the future.
Again, Happy New Year. Keep up with us in 2022 to see how else Norlase will bring innovation to laser photocoagulators.
Happy New Year from your friends at Norlase.
If 2020 was a year of transformation, then 2021 was a year of achievement. We ended our first week of the year with CE Mark approval for the LION green laser system, and our last week of the year clocking a 500% year-over-year growth in sales.Our customers now include most of the top-ranked ophthalmic hospitals in the United States. While the ongoing global pandemic created new logistical and personal challenges to overcome, these achievements bookended a year of incredible momentum in several key areas, including product innovation, organizational growth, and brand power.
Here are just a few of the highlights you may have seen in the news:
-
Shortly after its CE Mark approval, LION won the 2021 PRISM Award for photonics innovation in the Medical Device category
-
We announced new global distributor partnerships, expanding our product reach to Croatia, Serbia, Slovenia, Poland, Ukraine, Russia, Japan, and Algeria
-
We were granted a patent by the USPTO for a novel Voice Control System for Ophthalmic Lasers
-
We closed $10.6 million in Series B funding through London-based venture capital firm West Hill Capital.
We were also thrilled to garner increased attention and coverage from key media players in the eye care industry, including Retina Today, Ocular Surgery News, Retinal Physician, and Ophthalmology Management. Several feature articles, highlighting our differentiated technology and approach, reached tens of thousands of eye care professionals in North America and beyond. Behind the scenes, we continued to gain significant traction with clinical thought leaders, leading care institutions, and industry strategic partners.
When live meetings made a long-awaited return in the fourth quarter of last year, it was deeply rewarding that our reputation preceded our arrival, a testament to our team’s immense dedication, professionalism, and capability. We were thankful for the opportunity to engage the eye care community firsthand and showcase our commitment to advancing the standard of care for ophthalmic laser treatment. With global representation (including our team and distributors) and a badass booth, to boot, we like to think it was a live debut for the books.
While the return to live meetings was certainly refreshing, it’s worth mentioning that 2021 was the year that we perfected remote demonstrations and training. Much of this was due to LEAF and LION’s ease of use, intuitive design and user-friendly interface. Our reps and global partners are some of the best in the industry too – so we must also give them credit. We love getting into practices and in front of our customers, and hope we’re able to see more of them this year. When meeting virtually is the only option, we’ll make it as seamless and enjoyable as possible.
The most rewarding aspect of 2021, however, was to see our products help doctors deliver vision-critical treatments around the world. Hearing stories of how LEAF and LION has helped expand the access to eye-care, makes it all worth it for us. Stories such as how Dr. Maria Berrocal carried out a treatment in Puerto Rico during a complete power outage, thanks to the battery-driven LION laser. Or how Retina Global, who we were proud to support throughout the year, were able to bring laser treatments to underserved communities with LION.
Although it’s fun to revel, our success depends on maintaining an eye on the future. In 2022, we will continue to create, develop, and commercialize world-class products that change perceptions, inspire action, and benefit millions of patients around the world. We are eternally grateful for both the success we’ve experienced, the people who made that success possible, and the opportunity to engage and serve our customers, both today, tomorrow, and well into the future.
Again, Happy New Year. Keep up with us in 2022 to see how else Norlase will bring innovation to laser photocoagulators.
DIDN’T FIND WHAT YOU’RE LOOKING FOR?
Let us know how we can help!
DIDN’T FIND WHAT YOU
WERE LOOKING FOR?
Let us know how we can help!
